Determination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance Radiotherapy

Last updated: February 22, 2012
Sponsor: University of Wisconsin, Madison
Overall Status: Completed

Phase

N/A

Condition

Neurofibromatosis

Cancer/tumors

Brain Cancer

Treatment

N/A

Clinical Study ID

NCT00214175
RO04323
NCI-P01 CA88960
  • Ages > 18
  • All Genders

Study Summary

The primary objective is to evaluate and quantify the reproducibility of functional magnetic resonance imaging (fMRI) maps of the eloquent brain areas corresponding to specific neurological functions based on activation maps obtained with different thresholds in patients with benign and biopsy proven low-grade brain neoplasms. Another objective is to access the impairment in neurological function in image guided intracranial radiotherapy using neurocognitive assessment tools and to derive dose response curves relating the impairment in a particular neurological function to the FED received by the area of eloquent brain corresponding to it.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Indication for brain radiotherapy.

  • Ability to undergo MRI scans and time to participate in neurocognitive testing.

Study Design

Total Participants: 44
Study Start date:
June 01, 2004
Estimated Completion Date:
January 31, 2011

Connect with a study center

  • University of Wisconsin Hospital and Clinics

    Madison, Wisconsin 53792
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.